3Noonan KL, Beck C,Helzmayer TA,et al. Quantitative analysis of MDR(multidrug resistance) genec expression in huruan tumors by polymerase chain reaction.Proc Natl Aead Sci USA,1990,87(18):7160-7164.
4Urbanski SJ, Edwards DR, Maitland A, et al. Expression of metalloproteinases and their inhibilors in primary pulmonary carcinomas.Br J Cancer,1992,66(6) :1188-1194.
5Polette M,Clavel C,Muller D,et al.Detection of mRNAs encoding collagenase-1 and strumelysin-2 in carcinomas of the head and neck in situ hybridization. Invasion Metastasis, 1991,11(2) :76-83.
6Muller D,Wolf C,Abecassis J.et al.lncreased stromelysin-3 gene expression is associated with increased local invasiveamss in head and neck squamous cell carcinoma.Cancer Res, 1993,53(1) :165-169.
7Wolf C,Riuyer N,Lutz Y,et al. Stromelysin-3 belongs to a subgroup of proteinases expressed in breast Carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Nail Acad Sci USA, 1993,90(5):1843-1847.
8Urbanski SJ, Edward DR, Hershfield N, et al. Expression pattern of metallo proteinases and their inhibitors changes with the progression of human sporadic coloreetal neoplasia. Diogn Mol Pathol, 1993,2(2) :81-89.
9Benyon RC;Arthur MJ.Extracellular matrix degradation and the role of hepatic stellate cells[J],2001(3).
10Hayakawa T;Yamashita K;Tanzawa K.Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1 ) for a wide range of cells-a possible new growth factor in serum[J],1992.